Long-term persistence with rituximab in patients with rheumatoid arthritis

摘要

ObjectivesTo investigate the long term persistence of rituximab (RTX) in a large observational RA cohort, investigate persistence of RTX when used as a first or second line biologic DMARD (bDMARD), to characterize subsequent bDMARD treatment following RTX.